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Scotland and the public health politics of independence
Understanding how devolution has shaped tobacco and alcohol policies should inform debates
ahead of the referendum
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When the Scottish government published its white paper setting
out the case for independence, Scotland’s Future,1 public health
policy was central to its account of the Scottish parliament’s
achievements. An emphasis on tackling longstanding health
problems through legislation for smoke-free public places and
minimum unit pricing for alcohol was unsurprising given the
status of these policies as landmark achievements of devolution
and the praise lavished on the commitment of successive
governments to deal with health inequalities.2
The white paper depicts independence as conferring the ability
“to use the full range of levers to promote good health,” yet it
is noticeably lacking in specific public health policy
commitments. More broadly, the future of public health has
received limited attention in the unfolding debates preceding
the forthcoming referendum. Discussion of health issues on the
pro-independence websites of the “vote yes” campaign and the
Scottish National Party focuses on the future of the NHS, while
BMA Scotland restricts its guidance on the implications of
independence to medical education, training, and professional
matters.3 An analysis of how the existing constitutional
settlement has shaped developments in public health is needed
to inform consideration of alternative futures.
When political devolution took effect in Scotland and Wales in
1999, it was expected to stimulate health policy experimentation
across the United Kingdom.4 Although the extent to which this
has resulted in substantively divergent policies is contested,5
the record of tobacco and alcohol control in Scotland illustrates
the scope afforded for innovation. As well as being the first
place in the UK to implement legislation for smoke-free public
places, Scotland has taken exploratory steps towards shaping
the supply of tobacco and alcohol products. It has done this
through the introduction of a register of all retailers selling
tobacco products, a public health supplement (or levy) on larger
retailers that sell both tobacco and alcohol, and a law to make
proxy sales of tobacco products to those under 18 years old
illegal.6 7 The Scottish government’s endorsement of
standardised tobacco product packaging,7 and its persistence on
minimum pricing, contrast starkly with the UK government’s
equivocations.8 The ambition to make Scotland “smoke-free”
by 2034 reinforces its claims to public health leadership within
the UK.5
Such policies suggest that Scottish policy makers are more
comfortable than their English counterparts with pursuing state
level interventions for public health.5 It therefore seems plausible
that an independent Scotland, with wider powers, could bring
further opportunities for a progressive public health agenda.
Prospects for further public health innovation can be assessed
by reflecting on the “policy window” created by devolution.9
Such windows occur when three streams coalesce: problems
(such as a crisis drawing attention to a problem), policies
(specific proposals), and politics (including political institutions,
public opinion, and party interests).
In Scotland, poor performances in international comparisons of
population health and health inequalities have undoubtedly
highlighted public health as a policy problem.10 Health
professions and advocacy groups arguably have a stronger
influence in Edinburgh (and Cardiff) than in Westminster,
reflecting smaller policy communities and a more accessible
policymaking system.4The exposure of policymakers to policies
proposed by health researchers and advocates may therefore
have been greater than in Westminster, whereas exposure to
opposing business interests may have been lower, given the
small number of think tanks, consultancy groups, and
commercial headquarters in Scotland.11 Finally, survey data
showing greater public acceptance of state interventions,12
combined with the interest of the dominant Scottish National
Party in demonstrating strong leadership, suggest a favourable
political stream.
Some of these factors would probably persist in an independent
Scotland, including a policy concern with Scotland’s poor public
health and public support for state led health interventions. More
speculatively, the political momentum behind innovation in
public health could be partially self fulfilling, and could offer
a small new state a rare opportunity for global leadership. Yet
there are also reasons to question any assumption that an
independent Scotland would offer increased opportunities for
public health innovation. Currently, health is one of the most
high profile policy areas controlled by the Scottish government,
promoting its position on the policy agenda. If Scotland were
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independent, the government’s expanded remit would cover
fiscal policy, foreign affairs, and defence, potentially reducing
the focus on public health. Moreover, the accessible and
consensual Scottish policymaking system that seems to have
favoured public health to date could work against it if
commercial interests increase investment in political activities
north of the border. Such changes could, for example, empower
attempts by the whisky industry to hold alcohol policies hostage
to national interests in expanding whisky exports.13
The white paper itself cannot clearly guide an appraisal of such
prospects. It does suggest that the “greater scope and clearer
powers” afforded by independence would lead to further
strengthening of alcohol and tobacco regulation. It similarly
implies that powers over taxation and advertising regulation
would facilitate “a coherent and concerted approach to issues
of obesity and poor diet.”1Yet, the core commitment to undercut
the UK government on corporation tax highlights the strategic
priority of creating a business friendly Scotland, and in this
context maintaining political will to prioritise the interests of
public health over those of the food and drinks industry may
prove difficult.
Infatuation with policy innovation can lead to an exaggeration
of the real dividends of devolution for the health of people in
Scotland,2 and the scope for any government to tackle the social
determinants of health without control over economic policy,
trade, or international relations is clearly restricted. Yet,
devolution does seem to have provided public health with an
important window of opportunity. It should not be assumed that
this window will remain open for long, or that it would open
more widely in an independent Scotland.
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